Lebanese oncologists face challenges to stay updated with their practice, mainly due to time constraints.
The vast amount of data that is being published in the field, and their clinical and academic responsibilities, are the main reasons for these time limitations.
Despite that physicians are specialised, oncologists in Lebanon tend to treat all type of cancers. Besides, because of multiple reimbursement systems that follow different international guidelines they need to be aware of the latest updates within the pertinent guidelines.
Oncologists typically rely on multiple sources of scientific information to get updated like journals (New England Journal of Medicine, Annals of oncology, etc); congresses (ASCO, ESMO, etc) or the presentations (slides) from these congresses; and web resources (NCCN guidelines).
Typical scenarios for their update and search of information include:
Currently some of these physicians access the information in printed format (eg. printed versions of journals or reprints), while others tend to use different digital channels such as websites, mobile apps, informative email newsletters, platforms of medical societies or major guideline platforms (eg from EU or the FDA in the USA).
For some of them, access to the content (eg. the scientific papers) is also an issue as they have no budget support to cover the costs and must take care of it themselves.
MSD seeks to establish itself as a valuable stakeholder within the Health ecosystem by, among others, supporting physicians in their continuous medical education. Apart from Lebanese oncologists, gynecologists and internal medicine doctors will also be able to benefit from this support.
MSD Lebanon aims to enter into a co-creation process with an external partner that provides the service that includes the use of a digital solution that helps oncologists to stay updated with relevant clinical content about cancer updates.
The applicant must be able to provide both the content and the technological platform to deliver it to the Lebanese doctors.
Consortiums of complementary companies are eligible to participate, but the prize and travel support will not be increased so they have to be split among the consortium partners. A leading partner has to be designated in this case.
The applicant must be able to manage the whole life-cycle of the content (identification, selection, tagging, uploading, etc)
Besides, the digital solution delivering the content must be:
Desirable features include:
Regarding the scenarios to be supported, the order of priority is:
Note that any technology is welcome in the proposal with the exception of chatbots.
The solution should be able to track and provide analytics, at a minimum, on the indicators above, at grouped and individual level.
MSD Initially aims for a sponsorship model where, apart from the $20.000 grant, it will support the selected partner with:
1. MSD expert personnel for co-creating the solution (at Medical, Legal, Marketing levels), and supporting in its adaptation to the Lebanese market, including clinical landscape, regulation, cultural aspects, etc.
2. Proposal of clinical sources and/or papers of interest.
3. Access and networking with scientific societies, as well as the key Scientific Leaders in Lebanon.
4. Delivery of business support for business modelling and commercialization in collaboration with external experts.
5. Support the market rollout leveraging local MSD channels (eg. via professional medical representatives).
6. Local Social Media channels for Public Relations and solution sharing.
The total estimated co-creation period is 12 months, counting from the Selection event.
It will likely have the following phases and duration:
MSD Lebanon is initially considering a sponsorship model, where it economically supports the service but it does not own it. Ownership will stay on the winner of the challenge.